A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients
Clinical trial NCT01210768 · UNKNOWN
Trial details
- NCT number
- NCT01210768
- Sponsor
- TTY Biopharm
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2022-10-31
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.